<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03460873</url>
  </required_header>
  <id_info>
    <org_study_id>2015-11-037</org_study_id>
    <nct_id>NCT03460873</nct_id>
  </id_info>
  <brief_title>Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate</brief_title>
  <official_title>Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prognostic factor in the patients with benign prostatic hyperplasia (BPH) who undergo holmium
      laser enucleation of the prostate
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2015</start_date>
  <completion_date type="Actual">November 28, 2019</completion_date>
  <primary_completion_date type="Actual">November 7, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of IPSS(International Prostate Symptom Score) changes</measure>
    <time_frame>pre-operation and post-operation (3month, 6month)</time_frame>
    <description>Complete the questionnaire(IPSS) before and after the treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>changes of voided urine volume</measure>
    <time_frame>pre-operation and post-operation (3month, 6month)</time_frame>
    <description>Comparison of voided urine volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes of residual urine volume</measure>
    <time_frame>pre-operation and post-operation (3month, 6month)</time_frame>
    <description>Comparison of residual urine volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of adverse event</measure>
    <time_frame>post-operation (3month, 6month)</time_frame>
    <description>collection of adverse event</description>
  </secondary_outcome>
  <enrollment type="Actual">432</enrollment>
  <condition>Benign Prostatic Hyperplasia (BPH)</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>holmium laser enucleation of the prostate</intervention_name>
    <description>undergo holmium laser enucleation of the prostate</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        tertiary hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male patient scheduled to undergo prostatectomy using holmium laser

        Exclusion Criteria:

          -  Urethral stricture, large bladder diverticulum, bladder neck contracture
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Male patient scheduled to undergo prostatectomy using holmium laser</gender_description>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Samsung Medical Center, Sungkyunkwan University School of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>February 27, 2018</study_first_submitted>
  <study_first_submitted_qc>March 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2018</study_first_posted>
  <last_update_submitted>November 28, 2019</last_update_submitted>
  <last_update_submitted_qc>November 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>KYU-SUNG LEE</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Hyperplasia</mesh_term>
    <mesh_term>Hyperplasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

